Ding, Sijia
Xie, Lijun
Wang, Lu
Zhou, Chen
Zhou, Sufeng
Chen, Juan
Zhu, Bei
Liu, Yun
Zhu, Jinying
Zhang, Zeru
Li, Tongtong
Wang, Li
Zhang, Zhen
Shao, Feng http://orcid.org/0000-0001-8861-7299
Article History
Accepted: 27 November 2022
First Online: 15 December 2022
Declarations
:
: This study was funded by Xuanzhu (Beijing) Pharmaceutical Technology Co., Ltd.
: The authors have indicated that they have no conflicts of interest associated with the content of this article.
: This study was approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All participants provided written informed consent.
: Not applicable.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: Not applicable.
: Substantial contributions to the conception and design of the work were made by F.S. Administrative support and provision of study materials or participants were carried out by S.D., L.X., C.Z., S.Z., Z.Y., J.C., B.Z., J.Z., T.L., and Zeru.Z. Substantial contributions to collection and assembly of data were made by S.D., L.X., and J.C. Substantial contributions to data analysis and interpretation were made by L.W. and F.S. Substantial contributions to manuscript writing were made by S.D., L.X., L.W., F.S., and Y.L. made substantial contributions to quality assurance of this clinical trial. Zhen.Z. substantially contributed to the clinical operation of this trial. Final approval of the manuscript was given by all the authors.